← Evidence map

ArticleDiscover oncology2025

The role of angiotensinogen, angiotensin II receptor type I and type II receptor polymorphisms (AGTR2 rs11091046, AGT rs699, AGTR1 rs5186, and AGT rs4762) in multiple myeloma.

Istemi Serin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

The role of angiotensinogen, angiotensin II receptor type I and type II receptor polymorphisms (AGTR2 rs11091046, AGT rs699, AGTR1 rs5186, and AGT rs4762) in multiple myeloma. | OpenQuestion